Ocular manifestations of congenital toxoplasmosis

Eye

Volumn 24, Issue 4, 2010, Pages 528-534

  Melamed, J ^a,b   Eckert, G U ^b   Spadoni, V S ^b   Lago, E G ^c   Uberti, F ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Congenital toxoplasmosis; Ocular manifestations; Toxoplasma gondii

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANTERIOR EYE SEGMENT; ARTICLE; BIOMICROSCOPY; CATARACT; CHORIORETINITIS; CLINICAL ARTICLE; CONGENITAL TOXOPLASMOSIS; EXUDATE; EYE DISEASE; EYE EXAMINATION; EYE SYNECHIA; FEMALE; HUMAN; INFANT; MALE; MICROPHTHALMIA; MYDRIASIS; NEWBORN; NYSTAGMUS; OPHTHALMOSCOPY; PHTHISIS BULBI; PREVALENCE; RETINA NECROSIS; SKIAMETRY; STRABISMUS;

EID: 77951100866     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2009.140     Document Type: Article

References (37)

1. Remington JS, McLeod R, Thulliez P, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, Wilson CB, Baker CJ (eds). Infectious Diseases of the Fetus and Newborn Infant. 6th ed. Elsevier-Saunders: Philadelphia, 2006, pp 948-1091.
2. Spalding SM, Amendoeira MR, Ribeiro LC, Silveira C, Garcia AP, Camillo-Coura L. Estudo prospectivo de gestantes e seus bebês com risco de transmissão de toxoplasmose congênita em município do Rio Grande do Sul. Rev Soc Bras Med Trop 2003; 36(4): 483-491.
3. Mozzatto L, Procianoy RS. Incidence of congenital toxoplasmosis in southern Brazil: a prospective study. Rev Inst Med Trop Sao Paulo 2003; 45(3): 147.
4. Lago EG, Neto EC, Melamed J, Rucks AP, Presotto C, Coelho JC et al. Congenital toxoplasmosis: late pregnancy infections detected by neonatal screening and maternal serological testing at delivery. Paediatr Perinat Epidemiol 2007; 21: 525-531.
5. Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counseling. Lancet 1999; 353: 1829-1833.
6. Gilbert RE. Toxoplasmosis. In: Newel ML, McIntyre J (eds). Congenital and Perinatal Infections. Cambridge University Press: Cambridge, 2000, p 305.
7. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363: 1965-1976.
8. Wilson CB, Remington JS, Stagno S, Reynolds DW. Development of adverse sequelae in children born with subclinical congenital toxoplasma infection. Pediatrics 1980; 66: 767-774.
9. Lower-Sieger DH, Rothova A, Koppe JG, Kylstra A. Congenital toxoplasmosis, a prospective study based on 1821 pregnant women. In: Saari KM (ed). Uveitis UpdateQ2. Elsevier Science Publishers; Amsterdam-New York, 1984, pp 203-207.
10. Koppe JG, Loewer Sieger DH, de Roever Bonnet H. Results of 20-year follow-up of congenital toxoplasmosis. Lancet 1986; 1: 254-255.
11. Figueiredo ARP, Oréfice F, Caiaffa WT, Antunes CMF, Chiari CA. Aspectos oftalmológicos da associação toxoplasmose congênita - deficiência mental. Arq Bras Oftalmol 1989; 52: 84-89.
12. Peyron F, Wallon M, Bernardoux C. Long-term follow-up of patients with congenital ocular toxoplasmosis. N Engl J Med 1996; 334: 993-994.
13. Melamed J, Dornelles F, Eckert GU. Alterações tomográficas cerebrais em crianças com lesões oculares por toxoplasmose congênita. J Pediatr 2001; 77: 475-480.
14. Mets MB, Holfels E, Boyer KM, Swisher CN, Roizen N, Stein M et al. Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol 1996; 122: 309-324.
15. Meenken C, Assies J, van Nieuwenhuizen O, Holwerda-van der Maat WG, van Schooneveld MJ, Delleman WJ et al. Long-term ocular and neurological involvement in severe congenital toxoplasmosis. Br J Ophthalmol 1995; 79: 581-584.
16. François J. La Toxoplasmose et ses Manifestations Oculars. Editeurs Masson et Cie: Paris, 1963.
17. Pinheiro SRA, Orefice F, Andrade GMQ, Caiaffa WT. Estudo da toxoplasmose ocular em famílias de pacientes portadores de toxoplasmose congênita sistêmica e ocular. Arq Bras Oftalmol 1990; 53: 4-6.
18. Guerina NG, Hsu HW, Meissner HC, Maguire JH, Lynfield R, Stechenberg B et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. N Engl J Med 1994; 330: 1858-1863.
19. Orefice F, Pinheiro SRA, Ferreira CD. Calcificações no plano coróide -retina de pacientes com lesões cicatrizadas de toxoplasmose congênita diagnosticadas pela tomografia computadorizada. Rev Bras Oftalmol 1989; 48: 49-53.
20. Bahia MD, Oréfice F, Andrade CMQ. Análise clínica das lesões de retinocoroidite em crianças portadoras de toxoplasmose congênita. Rev Bras Oftalmol 1992; 51: 265-271.
21. Vutova K, Peicheva Z, Popova A, Markova V, Mincheva N, Todorov T. Congenital toxoplasmosis: eye manifestations in infants and children. Ann Trop Paediatr 2002; 22: 213-218.
22. Kodjikian L, Wallon M, Fleury J, Denis P, Binquet C, Peyron F et al. Ocular manifestations in congenital toxoplasmosis. Graefes Arch Clin Exp Ophthalmol 2006; 244: 14-21.
23. Couvreur J, Desmonts G, Aron-Rosa D. Le pronostic oculaire de la toxoplasmose congénitale: rôle du traitement. Ann Pédiatr 1984; 31: 855-858.
24. Hohlfeld P, Daffos F, Thulliez P, Aufrant C, Couvreur J, MacAleese J et al. Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr 1989; 115: 765-769.
25. Mc Auley J, Boyer KM, Patel D, Mets M, Swisher C, Roizen N et al. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago collaborative treatment trial. Clin Infect Dis 1994; 18: 38-72.
26. Brézin AP, Thulliez P, Couvreur J, Nobré R, McLeod R, Mets MB. Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis. Am J Ophthalmol 2003; 135: 779-784.
27. McLeod R, Boyer K, Karrison T, Kasza K, Swisher C, Roizen N et al. Outcome of treatment for congenital toxoplasmosis, 1981-2004: The National Collaborative Chicago-based, Congenital Toxoplasmosis Study. Clin Infect Dis 2006; 42: 1383-1394.
28. Gras L, Gilbert RE, Ades AE, Dunn DT. Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis. Int J Epidemiol 2001; 30: 1309-1316.
29. Petersen E. Toxoplasmosis. Semin Fetal Neonatal Med 2007; 12: 214-223.
30. Lebech M, Joynson DHM, Seitz HM, Thulliez P, Gilbert RE, Dutton GN et al. Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. Eur J Clin Microbiol Infect Dis 1996; 15: 799-805.
31. Holland GN, Buhles WC, Mastre B, Kaplan HJ. A controlled retrospective study of gancyclovir treatment for cytomegalovirus retinopathy. Arch Ophthalmol 1989; 107: 1759-1766.
32. Melamed J. Peculiarities of Ocular Toxoplasmosis in Rio Grande do Sul, Brazil. World Uveitis SymposiumQ3. Roca. Roca Publishers; São Paulo, 1989, pp 339-348.
33. Neves JM, Nascimento LB, Ramos JGL, Martins-Costa SH. Toxoplasmose na gestação. Rev Bras Ginecol Obstet 1994; 16: 197-202.
34. Tan HK, Schmidt D, Stanford M, Teär-Fahnehjelm K, Ferret N, Salt A et al. Risk of visual impairment in children with congenital toxoplasmic retinochoroiditis. Am J Ophthalmol 2007; 144: 648-653.
35. Boothhroid JC, Grigg ME. Population biology of Toxoplasma gondii and its relevance to human infections: do different strains cause different disease? Curr Opin Microbiol 2002; 5: 438-442.
36. Kahn A, Jordan C, Muccioli C, Vallochi AL, Rizzo LV, Belfort R et al. Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis, Brazil. Emerg Infect Dis 2006; 12: 942-949.
37. Gilbert RE, Freeman K, Lago EG, Bahia-Oliveira LMG, Tan HK, Wallon M et al. Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS, Negl Trop Dis 2008; 2: 1-7.